Breast cancer models predominantly expressed CYP2J2 and CYP2S1, whereas CYP3A and CYP2C subfamily members were enriched in hepatic cancer, underscoring their roles in xenobiotic metabolism and drug clearance. The gene discussed is CYP2J2; the disease is breast carcinoma.